Search

Your search keyword '"Calender A."' showing total 944 results

Search Constraints

Start Over You searched for: Author "Calender A." Remove constraint Author: "Calender A."
944 results on '"Calender A."'

Search Results

52. Sarcoidosis: A Clinical Overview from Symptoms to Diagnosis

57. Novel KCNQ2 and KCNQ3 Mutations in a Large Cohort of Families with Benign Neonatal Epilepsy: First Evidence for an Altered Channel Regulation by Syntaxin-1A

58. Thymic Neuroendocrine Tumors in Multiple Endocrine Neoplasia Type 1: A Comparative Study on 21 Cases Among a Series of 761 MEN1 from the GTE (Groupe des Tumeurs Endocrines)

59. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

60. Clinical aspects of multiple endocrine neoplasia type 1

61. Autophagy and Mitophagy-Related Pathways at the Crossroads of Genetic Pathways Involved in Familial Sarcoidosis and Host-Pathogen Interactions Induced by Coronaviruses

62. Is the early-onset torsion dystonia (EOTD) linked to TOR1A gene as frequent as expected in France?

63. Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk.

65. Sequence variations of ACVRL1 play a critical role in hepatic vascular malformations in hereditary hemorrhagic telangiectasia

66. Modeling Potential Autophagy Pathways in COVID-19 and Sarcoidosis

67. Homozygous mutations of ARFGAP1 gene in severe sarcoidosis

68. Whole Exome Sequencing study in a subgroup of sarcoidosis patients presenting an opportunistic infection with Cryptococcus neoformans

69. Autophagy is closely related to the inflammatory process in sarcoidosis uveitis

70. Whole Exome Sequencing in familial sarcoidosis targets pathways which may help early diagnosis of severe forms of sarcoidosis

71. Current Insights in Genetics of Sarcoidosis: Functional and Clinical Impacts

72. Sarcoidosis and the mTOR, Rac1, and Autophagy Triad

73. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

74. Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers (Nature Communications, (2021), 12, 1, (1078), 10.1038/s41467-020-20496-3).

75. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.

78. Genotype-phenotype correlations in hereditary hemorrhagic telangiectasia: Data from the French-Italian HHT network

80. Sarcoidosis: A Clinical Overview from Symptoms to Diagnosis

81. Sarco-IO : Étude des facteurs de risque associés à la survenue d’une infection opportuniste chez les patients porteurs d’une sarcoïdose

82. Higher risk of death among MEN1 patients with mutations in the JunD interacting domain: a Groupe d’étude des Tumeurs Endocrines (GTE) cohort study

90. Surveillance and Datalink Communication Performance Analysis for Distributed Separation Assurance System Architectures

91. Novel mutations in EPM2A and NHLRC1 widen the spectrum of Lafora disease

93. Characterization of the mouse Men1 gene and its expression during development

94. Expression and chromosomal localization of the Requiem gene

95. Mutations in Regulatory Subunit Type 1A of Cyclic Adenosine 5′-Monophosphate-Dependent Protein Kinase (PRKAR1A): Phenotype Analysis in 353 Patients and 80 Different Genotypes

98. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

99. Linkage disequilibrium studies in multiple endocrine neoplasia type 1 (MEN1)

100. Mapping of the gene encoding the B56β subunit of protein phosphatase 2A (PPP2R5B) to a 0.5-Mb region of chromosome 11q13 and its exclusion as a candidate gene for multiple endocrine neoplasia type 1 (MEN1)

Catalog

Books, media, physical & digital resources